Inventor · disambiguated record
Ian Maclachlan
Also filed as: MACLACHLAN IAN
51 granted patents·40 pending applications·5,958 citations·filing 1999–2024
99Inventor score
Files withPROTIVA BIOTHERAPEUTICS INC46ARBUTUS BIOPHARMA CORP17MACLACHLAN IAN12HEYES JAMES3UNIV BRITISH COLUMBIA2
Top patents by PatentIndex Score
91 records- 0199US9074208B2Modified siRNA molecules and uses thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Granted Jul 7, 2015·94 cites·44 claims
- 0299US8513403B2Modified siRNA molecules and uses thereofMACLACHLAN IAN·Filed 2012·Granted Aug 20, 2013·114 cites·27 claims
- 0399US8101741B2Modified siRNA molecules and uses thereofMACLACHLAN IAN·Filed 2006·Granted Jan 24, 2012·252 cites·43 claims
- 0499US7915399B2Modified siRNA molecules and uses thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2007·Granted Mar 29, 2011·148 cites·11 claims
- 0599US7799565B2Lipid encapsulated interfering RNAPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Granted Sep 21, 2010·367 cites·26 claims
- 0699US7745651B2Cationic lipids and methods of usePROTIVA BIOTHERAPEUTICS INC·Filed 2005·Granted Jun 29, 2010·368 cites·4 claims
- 0798US12016929B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2024·Granted Jun 25, 2024·5 cites·22 claims
- 0898US11786598B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2022·Granted Oct 17, 2023·7 cites·17 claims
- 0998US11141378B2Lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2021·Granted Oct 12, 2021·42 cites·30 claims
- 1098US9878042B2Lipid formulations for delivery of therapeutic agents to solid tumorsPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Jan 30, 2018·23 cites·18 claims
- 1198US9504651B2Lipid compositions for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Nov 29, 2016·144 cites·14 claims
- 1298US9492386B2Liposomal apparatus and manufacturing methodsPROTIVA BIOTHERAPEUTICS INC·Filed 2012·Granted Nov 15, 2016·72 cites·20 claims
- 1398US9364435B2Lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Jun 14, 2016·194 cites·20 claims
- 1498US9018187B2Cationic lipids and methods for the delivery of therapeutic agentsPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Granted Apr 28, 2015·116 cites·33 claims
- 1598US8999950B2Compositions and methods for silencing aldehyde dehydrogenasePROTIVA BIOTHERAPEUTICS INC·Filed 2012·Granted Apr 7, 2015·102 cites·35 claims
- 1698US8822668B2Lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Granted Sep 2, 2014·99 cites·23 claims
- 1798US8492359B2Lipid formulations for nucleic acid deliveryYAWORSKI EDWARD·Filed 2011·Granted Jul 23, 2013·109 cites·21 claims
- 1898US8283333B2Lipid formulations for nucleic acid deliveryYAWORSKI ED·Filed 2010·Granted Oct 9, 2012·313 cites·39 claims
- 1998US8188263B2Modified siRNA molecules and uses thereofMACLACHLAN IAN·Filed 2009·Granted May 29, 2012·241 cites·28 claims
- 2098US8058069B2Lipid formulations for nucleic acid deliveryYAWORSKI EDWARD·Filed 2009·Granted Nov 15, 2011·585 cites·22 claims
- 2198US7982027B2Lipid encapsulated interfering RNAPROTIVA BIOTHERAPEUTICS INC·Filed 2006·Granted Jul 19, 2011·228 cites·63 claims
- 2298US7901708B2Liposomal apparatus and manufacturing methodsPROTIVA BIOTHERAPEUTICS INC·Filed 2003·Granted Mar 8, 2011·344 cites·22 claims
- 2398US7803397B2Polyethyleneglycol-modified lipid compounds and uses thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2004·Granted Sep 28, 2010·313 cites·15 claims
- 2497US11318098B2Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2021·Granted May 3, 2022·3 cites·30 claims
- 2597US11298320B2Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2021·Granted Apr 12, 2022·3 cites·30 claims
- 2697US9187748B2Compositions and methods for silencing ebola virus gene expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Nov 17, 2015·93 cites·23 claims
- 2797US8936942B2Polyethyleneglycol-modified lipid compounds and uses thereofHEYES JAMES·Filed 2010·Granted Jan 20, 2015·111 cites·39 claims
- 2897US8569256B2Cationic lipids and methods for the delivery of therapeutic agentsHEYES JAMES·Filed 2010·Granted Oct 29, 2013·485 cites·20 claims
- 2997US7807815B2Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMAPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Granted Oct 5, 2010·68 cites·28 claims
- 3096US9428751B2Compositions and methods for silencing apolipoprotein C-III expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Aug 30, 2016·80 cites·15 claims
- 3196US8329070B2Liposomal apparatus and manufacturing methodMACLACHLAN IAN·Filed 2010·Granted Dec 11, 2012·158 cites·13 claims
- 3296US8236943B2Compositions and methods for silencing apolipoprotein BLEE AMY C H·Filed 2010·Granted Aug 7, 2012·234 cites·26 claims
- 3396US8227443B2Silencing of CSN5 gene expression using interfering RNAMACLACHLAN IAN·Filed 2010·Granted Jul 24, 2012·31 cites·20 claims
- 3495US11446383B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2018·Granted Sep 20, 2022·6 cites·17 claims
- 3595US8598333B2SiRNA silencing of genes expressed in cancerMACLACHLAN IAN·Filed 2007·Granted Dec 3, 2013·27 cites·8 claims
- 3695US7838658B2siRNA silencing of filovirus gene expressionMACLACHLAN IAN·Filed 2006·Granted Nov 23, 2010·181 cites·45 claims
- 3794US9926560B2Lipid encapsulating interfering RNAPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Mar 27, 2018·6 cites·14 claims
- 3893US9005654B2Systems and methods for manufacturing liposomesMACLACHLAN IAN·Filed 2006·Granted Apr 14, 2015·29 cites·16 claims
- 3993US9006191B2Silencing of polo-like kinase expression using interfering RNAMACLACHLAN IAN·Filed 2008·Granted Apr 14, 2015·19 cites·41 claims
- 4092US2024316206A1Novel lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 4190US8865675B2Compositions and methods for silencing apolipoprotein BHEYES JAMES·Filed 2011·Granted Oct 21, 2014·12 cites·46 claims
- 4290US8716464B2Compositions and methods for silencing Ebola virus gene expressionGEISBERT THOMAS W·Filed 2010·Granted May 6, 2014·11 cites·20 claims
- 4388US8455455B1Compositions and methods for silencing genes involved in hemorrhagic feverROBBINS MARJORIE·Filed 2011·Granted Jun 4, 2013·23 cites·30 claims
- 4488US2023372245A1Lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 4588US2024100166A1Novel lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 4686US9035039B2Compositions and methods for silencing SMAD4PROTIVA BIOTHERAPEUTICS INC·Filed 2012·Granted May 19, 2015·12 cites·37 claims
- 4783US10415037B2Compositions and methods for silencing hepatitis B virus gene expressionARBUTUS BIOPHARMA CORP·Filed 2015·Granted Sep 17, 2019·7 cites·23 claims
- 4880US9181545B2Lipid encapsulating interfering RNAMACLACHLAN IAN·Filed 2010·Granted Nov 10, 2015·1 cites·7 claims
- 4980US2023165973A1Compositions and methods for delivering messenger rnaARBUTUS BIOPHARMA CORP·Filed 2022·Application pending·0 cites
- 5079US2020268664A1Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2019·Application pending·0 cites
Showing the top 50 of 91 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ian Maclachlan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →